Imunon awarded Chief Medical Officer Faller Douglas Vincent 4,211 shares at $1.47 per share. The transaction represents about 10.2% of his resulting Imunon holding, which stood at 41,288 shares after the award and identifies the size of the grant relative to his post-transaction position.
Key Highlights
- The award price was $1.47 per share on September 11, 2026.
- Faller Douglas Vincent held 41,288 Imunon shares after the transaction.
- Transaction code A identifies the event as an award or grant representing about 10.2% of the resulting holding.
Imunon, Inc. (NASDAQ: IMNN) awarded 4,211 shares to Chief Medical Officer Faller Douglas Vincent. The shares were issued at $1.47 per share. The filing identifies this as an award to the company’s medical officer.
$1.47 Share Award Recorded on September 11
The transaction took place on September 11, 2026, with the per-share value set at $1.47. Faller Douglas Vincent was the named recipient in his role as Imunon’s Chief Medical Officer. The award covered 4,211 Imunon shares. Transaction code A classifies the event as an award or grant. The transaction identifies both the number of shares granted and the price assigned to each share. Those terms apply to the award made to Vincent.
Award Equals About 10.2% of Resulting Holding
Vincent’s Imunon position stood at 41,288 shares after the transaction. The 4,211-share award represented about 10.2% of that resulting holding. The percentage is measured against his post-transaction share position.
FAQs
Q: How many shares did Imunon Chief Medical Officer Faller Douglas Vincent receive?
A: Faller Douglas Vincent received 4,211 Imunon shares at $1.47 per share. The transaction identified him as the company’s Chief Medical Officer.
Q: What was Faller Douglas Vincent’s Imunon shareholding after the award?
A: Following the transaction, Vincent held 41,288 Imunon shares. The filing states that the 4,211-share award represented about 10.2% of his resulting holding.
Q: When did Imunon record the share award, and what did code A mean?
A: Imunon’s filing records the transaction on September 11, 2026. It uses transaction code A to identify the event as an award or grant.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.